haifa kathrin al-ali

University Hospital Halle (Saale)

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Collaborators (6)

Alessandro M. Vannucchi

Jean-Jacques Kiladjian

Paola Guglielmelli

Associate professor

Università degli Studi di Napoli Federico II

Dariusz Woszczyk

Head of Department

Opole University

Steffen Koschmieder

RWTH Aachen University

Michael Cross

Head of Laboratory Research

Leipzig University

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

haifa kathrin al-ali

Research Interests

Explore related searches

Contact this professor

Articles (10)

Collaborators (6)

Alessandro M. Vannucchi

Jean-Jacques Kiladjian

Paola Guglielmelli

Dariusz Woszczyk

Steffen Koschmieder

Michael Cross

Make your next move.

haifa kathrin al-ali

Research Interests

Explore related searches

Contact this professor

Articles (10)

Benefit of Early Ruxolitinib Initiation Regardless of Fibrosis Grade in Patients with Primary Myelofibrosis: A Post Hoc Analysis of the Single-Arm Phase 3b JUMP Study

BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis

Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)

Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning-Eudract #: 2007-002420-15.

Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients.

Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.

Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.

Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry.

Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.

Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low-, intermediate-1-, intermediate-2-, and high-risk myelofibrosis in JUMP, a Phase 3b, expanded-access study.

Collaborators (6)

Alessandro M. Vannucchi

Jean-Jacques Kiladjian

Paola Guglielmelli

Dariusz Woszczyk

Steffen Koschmieder

Michael Cross

Make your next move.